All In Biotech

Drug Trial Radar · NCT03129100

A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis

A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis

Last checked: Nov 20, 2026Latest source record: Jun 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 773 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

773

Actual

Start

May 9, 2017

Primary completion

May 26, 2020

Study completion May 27, 2021

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Apr 26, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate, in participants having achieved a state of sustained remission, if the ixekizumab treatment groups are superior to the placebo group in maintaining response during the randomized withdrawal-retreatment period in participants with axial spondyloarthritis.

Conditions

  • Axial Spondyloarthritis

Interventions

  • IxekizumabDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who do Not Experience a Flare (Combined Ixekizumab Treatment)Time frame: Week 64

Locations

127 sites in 23 countries. Site status is shown where the registry gives one.

  • Arizona Arthritis & Rheumatology Research

    Phoenix, Arizona

  • Care Access Research - Huntington Beach

    Huntington Beach, California

  • Desert Medical Advances

    Palm Desert, California

  • Arthritis Assoc. & Osteoporosis Ctr of Colorado Springs, LLC

    Colorado Springs, Colorado

  • Clinical Research Center of CT/NY

    Danbury, Connecticut

  • Arthritis Rheumatic Disease Specialties

    Aventura, Florida

  • Sarasota Arthritis Center

    Sarasota, Florida

  • Marietta Rheumatology

    Marietta, Georgia

  • Institute of Arthritis Research

    Idaho Falls, Idaho

  • Center for Arthritis & Osteoporosis

    Elizabethtown, Kentucky

  • Klein and Associates MD, PA

    Cumberland, Maryland

  • Klein and Associates MD, PA

    Hagerstown, Maryland

  • Arthritis Consultants Inc.

    St Louis, Missouri

  • Glacier View Research Institute

    Kalispell, Montana

  • Physician Research Collaboration, LLC

    Lincoln, Nebraska

  • Shanahan Rheumatology & Immunotherapy, PLLC

    Raleigh, North Carolina

  • Carolina Arthritis Associates

    Wilmington, North Carolina

  • Oregon Health and Science University

    Portland, Oregon

  • Altoona Center for Clinical Research

    Duncansville, Pennsylvania

  • Articularis Healthcare Group, INC dba Columbia Arthritis Ctr

    Columbia, South Carolina

  • Articularis Healthcare d/b/a/ Low Country Rheumatology, PA

    Summerville, South Carolina

  • Univ of Texas Health Science Center - Houston

    Houston, Texas

  • Arthritis Northwest PLLC

    Spokane, Washington

  • Consultorios Reumatologicos Pampa

    Ciudad Autonoma de Buenos Aire, Argentina

  • CIR Centro de Investigacions Reumatologicas

    San Miguel de Tucumán, Argentina

  • Clinica Adventista de Belgrano

    Ciudad de Buenos Aires, Buenos Aires, Argentina

  • CER Instituto Medico

    Quilmes, Buenos Aires, Argentina

  • Centro de Enfermedades del Higado y Aparato Digestivo

    Rosario, Santa Fe Province, Argentina

  • Centro Medico Privado de Reumatologia

    San Miguel de Tucumán, Tucumán Province, Argentina

  • KH der Barmherzigen Schwestern Wien BetriebsGesmbH

    Vienna, Austria

  • CIP - Centro Internacional de Pesquisa

    Goiás, Brazil

  • CMIP - Centro Mineiro de Pesquisa

    Juiz de Fora, Minas Gerais, Brazil

  • EDUMED - Educação em Saúde Ltda.

    Curitiba, Paraná, Brazil

  • CCBR Brasil Centro de Analises e Pesquisas Clínicas LTDA

    Rio de Janeiro, Rio de Janeiro, Brazil

  • Hospital de Clinicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil

  • LMK Serviços Médicos S/S

    Porto Alegre, Rio Grande do Sul, Brazil

  • Cpclin Centro de Pesquisas Clinicas

    São Paulo, São Paulo, Brazil

  • Group de recherche en maladies osseuses

    Québec, Canada

  • University of Alberta Hospital

    Edmonton, Alberta, Canada

  • St. Clare's Mercy Hospital

    St. John's, Newfoundland and Labrador, Canada

Showing 40 of 127 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.